Lancet
-
Randomized Controlled Trial Multicenter Study Comparative Study
Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial.
Adalimumab is indicated for the treatment of moderate to severe psoriasis in adults. We assessed the efficacy and safety of adalimumab in children and adolescents with severe plaque psoriasis. ⋯ AbbVie.
-
Multicenter Study
Mortality risks associated with emergency admissions during weekends and public holidays: an analysis of electronic health records.
Weekend hospital admission is associated with increased mortality, but the contributions of varying illness severity and admission time to this weekend effect remain unexplored. ⋯ NIHR Oxford Biomedical Research Centre.